TILMIUS

Welcome to the Brand page for “TILMIUS”, which is offered here for Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections, excluding pharmaceutical preparations for the treatment of osteoporosis and the prevention of fractures resulting from osteoporosis; pharmaceutical preparations for the treatment of car t-cell induced cytokine release syndrome, excluding pharmaceutical preparations for the treatment of osteoporosis and the prevention of fractures resulting from osteoporosis;.

Its status is currently believed to be active. Its class is unavailable. “TILMIUS” is believed to be currently owned by “Fresenius Kabi Deutschland GmbH”.